130 – A multivalent adenovirus-based immunotherapeutic for treatment of chronic hepatitis B induces broad, robust and polyfunctional T cells in naive and HBV tolerant mice.

Perrine Martin, et al.
Journal of Hepatology, 2013, (58), Supplement 1, S57–S58. – Download the article
Publication

Par alcyon|2019-07-03T12:16:48+02:00septembre 2nd, 2013|Publication, TG1050|Commentaires fermés